Wagle; Dilip

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wagle; Dilip.The latest application filed is for "method for treating congestive heart failure".

Company Profile

0.6.21

Wagle; Dilip - Pune IN
Wagle; Dilip - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for treating diabetic nephropathy App 20090124673 - Egan; John ; et al.	2009-05-14
Method for treating congestive heart failure App 20090124674 - Egan; John ; et al.	2009-05-14
Method for treating glaucoma IC Grant 7,432,254 - Egan , et al. October 7, 2	2008-10-07
Method for treating glaucoma IIB App 20070161616 - Wagle; Dilip ; et al.	2007-07-12
Method for treating fibrotic diseases and other indications Grant 7,166,625 - Egan , et al. January 23, 2	2007-01-23
Method for treating glaucoma III B App 20060287318 - Wagle; Dilip ; et al.	2006-12-21
Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds Grant 7,026,342 - Wagle , et al. April 11, 2	2006-04-11
Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging Grant 6,960,605 - Wagle , et al. November 1, 2	2005-11-01
Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds App 20050032788 - Wagle, Dilip ; et al.	2005-02-10
Method for treating fibrotic diseases or other indications IE App 20040235837 - Egan, John ; et al.	2004-11-25
Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds Grant 6,770,663 - Wagle , et al. August 3, 2	2004-08-03
Method for treating fibrotic diseases or other indications IIIC App 20040097495 - Wagle, Dilip ; et al.	2004-05-20
Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds App 20030225146 - Wagle, Dilip ; et al.	2003-12-04
Method for treating fibrotic diseases or other indications with imidazolium agents App 20030176426 - Wagle, Dilip ; et al.	2003-09-18
Method for treating fibrotic diseases or other indications IIC Grant 6,596,744 - Wagle , et al. July 22, 2	2003-07-22
Method for treating fibrotic diseases or other indications IIIC App 20020183365 - Wagle, Dilip ; et al.	2002-12-05
Method for treating fibrotic diseases or other indications IIC App 20020183317 - Wagle, Dilip ; et al.	2002-12-05
Method for treating fibrotic diseases or other indications ID App 20020177586 - Egan, John J. ; et al.	2002-11-28
Method for treating glaucoma IC App 20020160993 - Egan, John J. ; et al.	2002-10-31
Method for treating glaucoma IVB App 20020156073 - Wagle, Dilip ; et al.	2002-10-24
Method for treating glaucoma IIIB App 20020156080 - Wagle, Dilip ; et al.	2002-10-24
Method for treating glaucoma IIB App 20020119970 - Wagle, Dilip ; et al.	2002-08-29
Method for treating fibrotic diseases or other indications IVC App 20020107245 - Wagle, Dilip ; et al.	2002-08-08
Method for treating fibrotic diseases or other indications IC App 20020068729 - Egan, Jack ; et al.	2002-06-06
Thiazolium compounds and treatments of disorders associated with protein aging App 20020055527 - Wagle, Dilip ; et al.	2002-05-09
Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging App 20020022622 - Wagle, Dilip ; et al.	2002-02-21
Synthesis of thiazolium compounds App 20020013471 - Wagle, Dilip	2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.